1-6 of 6
Kelley M. Kidwell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1777.
https://doi.org/10.1158/1078-0432.CCR-20-0653
Published: 01 April 2020
View article titled, Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer
Open the PDF for Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer in another window
Journal Articles

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Daniel L. Hertz, Kelley M. Kidwell, Kiran Vangipuram, Feng Li, Manjunath P. Pai, Monika Burness, Jennifer J. Griggs, Anne F. Schott, Catherine Van Poznak, Daniel F. Hayes, Ellen M. Lavoie Smith, N. Lynn Henry
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3602–3610.
https://doi.org/10.1158/1078-0432.CCR-18-0656
Published: 31 July 2018
View article titled, Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
Open the PDF for Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy in another window
Includes: Supplementary data
Journal Articles

Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research

Kelley M. Kidwell, Michael A. Postow, Katherine S. Panageas
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (4): 730–736.
https://doi.org/10.1158/1078-0432.CCR-17-1355
Published: 14 February 2018
View article titled, Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research
Open the PDF for Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research in another window
Journal Articles

UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (20): 5087–5096.
https://doi.org/10.1158/1078-0432.CCR-15-2158
Published: 13 October 2016
View article titled, UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer
Open the PDF for UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Costanza Paoletti, Yufeng Li, Maria C. Muñiz, Kelley M. Kidwell, Kimberly Aung, Dafydd G. Thomas, Martha E. Brown, Vandana G. Abramson, William J. Irvin, Jr, Nancy U. Lin, Minetta C. Liu, Rita Nanda, Julie R. Nangia, Anna M. Storniolo, Tiffany A. Traina, Christos Vaklavas, Catherine H. Van Poznak, Antonio C. Wolff, Andres Forero-Torres, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (12): 2771–2779.
https://doi.org/10.1158/1078-0432.CCR-14-2781
Published: 14 June 2015
View article titled, Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Open the PDF for Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019 in another window
Includes: Supplementary data
Journal Articles

Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer

Costanza Paoletti, Maria C. Muñiz, Dafydd G. Thomas, Kent A. Griffith, Kelley M. Kidwell, Nahomi Tokudome, Martha E. Brown, Kimberly Aung, M. Craig Miller, Dorothy L. Blossom, Anne F. Schott, N. Lynn Henry, James M. Rae, Mark C. Connelly, David A. Chianese, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2487–2498.
https://doi.org/10.1158/1078-0432.CCR-14-1913
Published: 31 May 2015
View article titled, Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
Open the PDF for Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data